Author Archives: janice goh

Unknown's avatar

About janice goh

Dr. Janice Goh graduated from NUS Pharmacy and is a registered pharmacist with the Singapore Pharmacy Council. She recently completed her PhD in the lab of Professor Rada Savic at the University of California, San Francisco (UCSF) School of Pharmacy. She is currently a senior scientist at the Bioinformatics Institute, A*STAR. Her work focuses on using quantitative systems pharmacology using translational pharmacometrics tools by capitalising on preclinical data to predict clinical outcomes prior to actual trials.

Nonlinear mixed effect modeling – a bed time story

A long time ago before AI generated children’s books were a thing, I made children’s books using biorender for fun. Here’s one that I have not released before. I found it to be a fun way to explain what I … Continue reading

Posted in Uncategorized | Leave a comment

Export control in a digital world – is synthetic data the future for clinical studies?

Part 5 of ScienceJournalJourneys – Hi I am your SG pharmacometrician, an early career researcher here to share the latest trends and interesting facts in pharmacometrics When you bring goods to another country, it is normal for the goods to … Continue reading

Posted in Uncategorized | Tagged , , , , , , , | Leave a comment

Neural ODEs vs ODEs – what’s the difference?

Part 4 of ScienceJournalJourneys – Hi I am your SG pharmacometrician, an early career researcher here to share my expertise and learnings about everything pharmacometrics. For any PK/PD modeler, ODEs are a staple in our models that help us to … Continue reading

Posted in Uncategorized | Tagged , , , , , , | Leave a comment

ScienceJournalJourney3 – the translation problem in drug development

Drug development often follows a series of experiments of exponentially increasing costs. After identifying a target and a few hits, novel drugs are then tested in large scale against in vitro assays e.g. bacterial kill in a 96 well plate, … Continue reading

Posted in Uncategorized | Leave a comment

ScienceJournalJourney2 – The one surprising use of Fexofenadine (Telfast)

To the average consumer, fexofenadine, or better known by its brand name, Telfast, is a non-sedating anti-allergy medication that can help to stop itches and runny noses. Fexofenadine is an over-the-counter medication that does not require frequent monitoring or dose … Continue reading

Posted in Uncategorized | Leave a comment

Infinity stoned – a pharmacometrician’s take on Thanos in Squid Game 2

Disclaimer: this is purely a tongue in cheek article for educational purposes. In no way do I condone the use of illegal drugs or encourage its use. Also, potential spoilers ahead. Since the season 2 release, Squid Game is once … Continue reading

Posted in Uncategorized | Leave a comment

Has AI taken over my job? A comparison of ChatGPT and DeepSeek for generating NONMEM scripts

Prompt: Develop a 1 compartment oral absorption PK model with linear elimination in NONMEM I did a direct comparison of the script outputs in the table below. For the sake of brevity, only CL was discussed in the $PK block, … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , | Leave a comment

ScienceJournalJourney 1:  How do drug manufacturers make dosing recommendations?

Hi all, Happy New Year to everyone! I’m starting a new series this year called #ScienceJournalJourney where I review an interesting journal article and give a quick layman summary on it. As your favorite post doc influencer on LinkedIn, I … Continue reading

Posted in Uncategorized | Tagged , , , , , , | Leave a comment

Taking stock – has LinkedIn been useful for an early career scientist?

Its been slightly over a year since I started posting on LinkedIn. From approximately 300 ish followers, my following has grown to 2590 as of writing. Of note, I am happy to know that my coffee PK app has been … Continue reading

Posted in Uncategorized | Tagged , , , , | Leave a comment

Antibody pharmacokinetics (PK) and nonlinear clearance

Life has been rather busy lately, but I have been using my spare time to learn new things too. Having come from a background working mostly with small molecules, I have decided to take some time to learn about the … Continue reading

Posted in Uncategorized | Tagged , , , , , , , | Leave a comment